180 Life Sciences Corp. financial data

Symbol
ATNF, ATNFW on Nasdaq
Industry
Pharmaceutical Preparations
Location
3000 El Camino Real, Bldg 4, Ste 200, Palo Alto, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
KBL MERGER CORP. IV (to 11/6/2020)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 62.4 % -45.3%
Debt-to-equity -1.17K % -2009%
Return On Equity 3.04K %
Return On Assets -286 % -14.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 970K shares -81.8%
Common Stock, Shares, Outstanding 942K shares -74.9%
Entity Public Float 5.85M USD -76.9%
Common Stock, Value, Issued 95 USD -82.1%
Weighted Average Number of Shares Outstanding, Basic 919K shares +234%
Weighted Average Number of Shares Outstanding, Diluted 919K shares +234%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 488K USD -38.1%
General and Administrative Expense 1.22M USD -55.7%
Operating Income (Loss) -8.93M USD +50.9%
Nonoperating Income (Expense) -5.97M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.9M USD +71.7%
Income Tax Expense (Benefit) -2.35M USD
Net Income (Loss) Attributable to Parent -12.6M USD +75.7%
Earnings Per Share, Basic 0.01 USD/shares
Earnings Per Share, Diluted 35.8 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Other Assets, Current 53.2M USD
Assets, Current 2.35M USD -20%
Intangible Assets, Net (Excluding Goodwill) 1.56M USD -6.31%
Goodwill 0 USD
Assets 3.91M USD -71.4%
Accounts Payable, Current 2.56M USD +205%
Accrued Liabilities, Current 560K USD -77.6%
Liabilities, Current 4.02M USD -6.02%
Deferred Income Tax Liabilities, Net 300K USD -88.7%
Liabilities 4.33M USD -37.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.92M USD -0.54%
Retained Earnings (Accumulated Deficit) -128M USD -10.8%
Stockholders' Equity Attributable to Parent -418K USD -106%
Liabilities and Equity 3.91M USD -71.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.03M USD +73.3%
Net Cash Provided by (Used in) Financing Activities -264K USD +43.7%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 942K shares -82.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.3M USD +69.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.15M USD -42.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.1K USD +66.2%
Deferred Tax Assets, Valuation Allowance 18.7M USD +24.3%
Deferred Tax Assets, Gross 19.3M USD +23.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.6M USD +59%
Deferred Income Tax Expense (Benefit) 2.3M USD
Deferred Tax Assets, Operating Loss Carryforwards 16.5M USD +22.8%
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 131M USD +4.33%
Amortization of Intangible Assets 23.6K USD +8.29%
Share-based Payment Arrangement, Expense 22.3K USD -96%
Interest Expense 49.7K USD +326%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%